Persistent Depressive Disorder (Dysthymia)

Persistent Depressive Disorder, previously known as dysthymia, involves a chronic depressed mood present for most of the day, more days than not, for at least two years in adults (one year in children and adolescents). Because the symptoms are often less severe than a full major depressive episode but far more enduring, many people live with this chronic low mood for years, assuming it is simply their personality rather than a treatable medical condition. When a major depressive episode occurs on top of this chronic baseline, it is sometimes referred to as 'double depression.'

Persistent Depressive Disorder is defined as a depressed mood for most of the day, for more days than not, for at least two years (one year in children/adolescents), along with two or more additional symptoms (poor appetite or overeating, insomnia or hypersomnia, low energy or fatigue, low self-esteem, poor concentration or difficulty making decisions, or feelings of hopelessness), with no symptom-free period lasting more than two months during that time.

Persistent Depressive Disorder shares genetic and neurobiological vulnerability with Major Depressive Disorder but tends to reflect a more chronic, trait-like pattern of dysregulation. Early onset is often linked to childhood adversity, chronic family stress, or an early-emerging depressive or anxious temperament, while chronic ongoing stress can maintain the low-grade symptoms over years.

• Family history of depression
• Childhood adversity, trauma, or chronic family stress
• Chronic ongoing life stress
• Co-occurring anxiety disorders or other psychiatric conditions
• Chronic medical illness

Persistent Depressive Disorder involves similar monoamine and HPA-axis dysregulation as Major Depressive Disorder, but the chronicity suggests a more stable, trait-like pattern of dysregulation rather than an acute, episodic disruption — which may partly explain why standard antidepressant trials sometimes need to be longer before a response is judged.

• Chronic low mood present most of the day, more days than not
• Poor appetite or overeating
• Insomnia or hypersomnia
• Low energy or fatigue
• Low self-esteem
• Poor concentration or difficulty making decisions
• Feelings of hopelessness

• Depressed mood for most of the day, more days than not, for 2+ years (1+ year in children/adolescents)
• Two or more additional characteristic symptoms present during that period
• No symptom-free period lasting more than 2 months during the 2 years
• May include superimposed major depressive episodes ('double depression')
• Not attributable to a substance or another medical condition
• Not better explained by a psychotic disorder, and no history of mania/hypomania

Conditions a psychiatrist will consider and rule out before confirming this diagnosis:

Major Depressive Disorder

MDD is typically more acute and episodic, whereas Persistent Depressive Disorder is continuous and chronic — the two can co-occur as 'double depression.'

Bipolar II Disorder

Screening for past hypomanic episodes is essential before assuming a purely depressive course.

Personality disorders

Chronic low self-esteem and negative self-view can overlap with certain personality disorder features, requiring careful longitudinal assessment.

Chronic medical illness with secondary depression

Ongoing physical illness can produce a similarly chronic low mood; both conditions may need concurrent management.

• Detailed longitudinal clinical interview establishing the chronicity and continuity of symptoms
• PHQ-9 questionnaire
• Thyroid function tests
• Screening for any history of hypomania or mania

Given the chronic nature of this condition, a combination of psychotherapy and antidepressant medication is often more effective than either alone. Cognitive Behavioral Analysis System of Psychotherapy (CBASP), developed specifically for chronic depression, has strong supporting evidence alongside standard CBT and IPT approaches.

SSRIs (e.g., sertraline, escitalopram)

First-line, similar to MDD, though a longer treatment trial may be needed given the chronic nature of symptoms.

SNRIs (e.g., venlafaxine)

An effective alternative.

Cognitive Behavioral Analysis System of Psychotherapy (CBASP)

A therapy model developed specifically for chronic depression, focusing on interpersonal patterns and problem-solving.

Cognitive Behavioral Therapy (CBT)

Addresses long-standing negative thought patterns.

Interpersonal Therapy (IPT)

Addresses chronic relationship patterns that may maintain low mood.

• Regular exercise and consistent sleep habits, as with major depression
• Structured engagement in previously enjoyable activities, even when motivation is chronically low
• Building and maintaining social connection despite the pull toward withdrawal
• Tracking mood over time to recognize that the chronic low mood is not simply 'personality' but a treatable pattern

Persistent Depressive Disorder follows a chronic course, but responds well to a sustained combination of psychotherapy and medication. Because symptoms have often been present so long, treatment engagement can be delayed until the person recognizes their baseline mood is not normal — earlier recognition generally leads to a better outcome.

• Early identification and treatment of childhood or adolescent depressive symptoms before they become chronic
• Addressing chronic family or life stressors that maintain low mood
• Treating co-occurring anxiety or other psychiatric conditions promptly

Recognize that persistent low mood, even without the dramatic presentation of an acute depressive episode, is a real and treatable illness — not simply a pessimistic or difficult personality. Because the person may have normalized feeling this way for years, gentle encouragement to seek assessment can be especially valuable, along with patience, since chronic depression often takes longer to respond fully to treatment than an acute episode.

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, Text Revision (DSM-5-TR).
2. World Health Organization. International Classification of Diseases, 11th Revision (ICD-11).